Basit öğe kaydını göster

dc.contributor.authorErden, Sacide
dc.contributor.authorGelincik, Ash
dc.contributor.authorVural, Pervin
dc.contributor.authorDegirmencioglu, Sevgin
dc.date.accessioned2021-03-03T16:51:50Z
dc.date.available2021-03-03T16:51:50Z
dc.date.issued2009
dc.identifier.citationVural P., Degirmencioglu S., Erden S., Gelincik A., "The relationship between transforming growth factor-beta 1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis", INTERNATIONAL IMMUNOPHARMACOLOGY, cilt.9, sa.2, ss.212-215, 2009
dc.identifier.issn1567-5769
dc.identifier.othervv_1032021
dc.identifier.otherav_469f5407-27c8-47f9-9e19-8553014b76c4
dc.identifier.urihttp://hdl.handle.net/20.500.12627/51066
dc.identifier.urihttps://doi.org/10.1016/j.intimp.2008.11.003
dc.description.abstractBackground: Hashimoto's thyroiditis (HT) is one of the autoimmune disorders of the thyroid gland. The pathogenesis of HT has not been clearly understood. This study was designed to investigate plasma transforming growth factor-beta 1 (TGF-beta 1), vascular endothelial growth factor (VEGF), and nitrate/nitrite (NOx-two end products of nitric oxide [NO] metabolism) in HT.
dc.language.isoeng
dc.subjectYaşam Bilimleri
dc.subjectEczacılık
dc.subjectTemel Bilimler
dc.subjectSağlık Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectİmmünoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.titleThe relationship between transforming growth factor-beta 1, vascular endothelial growth factor, nitric oxide and Hashimoto's thyroiditis
dc.typeMakale
dc.relation.journalINTERNATIONAL IMMUNOPHARMACOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume9
dc.identifier.issue2
dc.identifier.startpage212
dc.identifier.endpage215
dc.contributor.firstauthorID45340


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster